Today’s stock pick update – Open Now

[Learn More]( [Best-Selling Trading Author Just Released New Ebook]( He's giving it away for a limited time! Inside you'll learn: - How To Use The Market To Finance The Things You Need Most - A Unique Strategy That Could Help Pay Your Monthly Utilities - How To Minimize Risk and Maximize Gains With Options And much more!(Ad) [Claim Your Copy Here]( Dell May Be About To Spinoff Its Stake In VMware & Shares Are Climbing The White House is weighing new tariffs on $3.1 billion of exports from France, Germany, Spain, and the U.K., for products including olives, chocolate, beer, gin, and trucks. The American Trade Representative is seeking to impose the new tariffs alongside increased duties of up to 100% on products including aircrafts, cheese, and yogurt. The move is part of a wider reaction from the U.S. in relation to a long-standing dispute with the European Union over subsidies to large ci... [Read More]( Penn National Gaming (NASDAQ: [PENN]( Penn National Gaming shares gained as much as 19% yesterday after CEO Jay Snowden said the company has resumed operations at 30 out of 41 of its gaming and racing properties across 13 states, and said that the rest of the properties will open in the “coming weeks.” Snowden [Read More]( [Is COP a good value bet on stabilizing oil prices?]( Among the various macroeconomic factors I try to pay attention to is the ebb and flow of oil prices. I think oil is one of the most interesting commodities of all; no matter whether you drive a gas-guzzler, an electric vehicle or a hybrid, the truth is that oil is a factor in every sector of the market, with tentacles that reach into economic policy and most certainly into geopolitics. [Read More]( Featured Stock [IVERIC bio, Inc. (ISEE) – Buy Price: $6.25 or better]( IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company is developing Zimura, an inhibitor of complement factor C5, which is in Phase IIb clinical trials for the treatment of geographic atrophy (GA), a late-stage form of dry age-related macular degeneration (AMD) characterized by retinal cell death and degeneration of tissue in the central portion of the retina known as the macula... [Read More]( Other Top Stories - [US investigates headlight failures in about 392,000 Kia SUVs]( - [How New Grads Can Handle 3 Essential Post-College Questions]( - [US probes complaints of sticky steering on older GM SUVs]( - [Virus cases surging among the young, endangering the elderly]( - [Bayer to pay up to $10.9 billion to settle Monsanto case]( Trend Following Picks - [IVERIC bio, Inc. (ISEE) – Buy Price: $6.25 or better]( - [Gerdau S.A. (GGB) – Buy Price: $3.25 or better]( - [Agenus Inc. (AGEN) – Buy Price: $4.25 or better]( - [Coffee Holding Co., Inc. (JVA) – Buy Price: $3.75 or better]( - [Kadmon Holdings, Inc. (KDMN) – Buy Price: $5.00 or better]( [All Picks]( Reversal Picks - [TETRA Technologies, Inc. (TTI) Buy Target $0.53 Sell Target $0.63]( - [CytomX Therapeutics, Inc. (CTMX) Buy Target $10.43 Sell Target $12.34]( - [Aytu BioScience, Inc. (AYTU) Buy Target $1.64 Sell Target $1.82]( - [Iovance Biotherapeutics, Inc. (IOVA) Buy Target $31.63 – Sell Target $36.42]( - [XBiotech Inc. (XBIT) – Buy Target $14.27 – Sell Target $15.19]( [All Picks]( Low Price Stock Picks - [Civeo Corporation (CVEO)]( - [Gold Standard Ventures Corp (GSV)]( - [Vista Gold Corp. (VGZ)]( - [Tyme Technologies, Inc. (TYME)]( - [Uranium Energy Corp. (UEC)]( [All Picks]( Already subscribed to our premium service? [Click here to Login.]( Not a TradersPro subscriber yet? [Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits]( --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019